nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A1—neck—salivary gland cancer	0.0489	0.0848	CbGeAlD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—ITGB4—salivary gland cancer	0.045	0.106	CbGpPWpGaD
Olopatadine—S100A13—neck—salivary gland cancer	0.0434	0.0753	CbGeAlD
Olopatadine—S100A2—parotid gland—salivary gland cancer	0.0432	0.075	CbGeAlD
Olopatadine—S100A2—saliva-secreting gland—salivary gland cancer	0.0414	0.0719	CbGeAlD
Olopatadine—S100A1—saliva-secreting gland—salivary gland cancer	0.0381	0.0662	CbGeAlD
Olopatadine—S100A2—epithelium—salivary gland cancer	0.0361	0.0627	CbGeAlD
Olopatadine—S100A1—connective tissue—salivary gland cancer	0.035	0.0608	CbGeAlD
Olopatadine—S100A13—connective tissue—salivary gland cancer	0.0311	0.0539	CbGeAlD
Olopatadine—S100A12—connective tissue—salivary gland cancer	0.0307	0.0532	CbGeAlD
Olopatadine—S100B—connective tissue—salivary gland cancer	0.0303	0.0525	CbGeAlD
Olopatadine—S100A13—epithelium—salivary gland cancer	0.0295	0.0512	CbGeAlD
Olopatadine—S100A12—epithelium—salivary gland cancer	0.0291	0.0505	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—salivary gland cancer	0.0278	0.0483	CbGeAlD
Olopatadine—S100A12—ZBP1(DAI) mediated induction of type I IFNs—DTX4—salivary gland cancer	0.0256	0.0603	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—JAG1—salivary gland cancer	0.0246	0.0581	CbGpPWpGaD
Olopatadine—S100B—ZBP1(DAI) mediated induction of type I IFNs—DTX4—salivary gland cancer	0.0242	0.0571	CbGpPWpGaD
Olopatadine—S100A12—lymphoid tissue—salivary gland cancer	0.0224	0.0389	CbGeAlD
Olopatadine—S100B—lymphoid tissue—salivary gland cancer	0.0221	0.0384	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—FOXO3—salivary gland cancer	0.015	0.0354	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—VCAN—salivary gland cancer	0.0147	0.0348	CbGpPWpGaD
Olopatadine—S100A1—lymph node—salivary gland cancer	0.0145	0.0251	CbGeAlD
Olopatadine—S100A13—lymph node—salivary gland cancer	0.0128	0.0223	CbGeAlD
Olopatadine—S100A12—lymph node—salivary gland cancer	0.0127	0.022	CbGeAlD
Olopatadine—S100B—lymph node—salivary gland cancer	0.0125	0.0217	CbGeAlD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—DTX4—salivary gland cancer	0.0121	0.0286	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—DTX4—salivary gland cancer	0.0115	0.0271	CbGpPWpGaD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—PRKDC—salivary gland cancer	0.0105	0.0248	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—PRKDC—salivary gland cancer	0.00995	0.0235	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—salivary gland cancer	0.00941	0.0222	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—salivary gland cancer	0.0089	0.021	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—EP300—salivary gland cancer	0.00841	0.0198	CbGpPWpGaD
Olopatadine—HRH1—connective tissue—salivary gland cancer	0.00621	0.0108	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—EP300—salivary gland cancer	0.0062	0.0146	CbGpPWpGaD
Olopatadine—HRH1—epithelium—salivary gland cancer	0.00589	0.0102	CbGeAlD
Olopatadine—S100A2—Direct p53 effectors—CREBBP—salivary gland cancer	0.00576	0.0136	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—FGF16—salivary gland cancer	0.00487	0.0115	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—MAP2K2—salivary gland cancer	0.00453	0.0107	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—MAP2K2—salivary gland cancer	0.00429	0.0101	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—PTEN—salivary gland cancer	0.00411	0.00971	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—MAP2K2—salivary gland cancer	0.0041	0.00968	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAP2K2—salivary gland cancer	0.00406	0.00959	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—MAP2K2—salivary gland cancer	0.00399	0.00942	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—EP300—salivary gland cancer	0.00392	0.00926	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—MAP2K2—salivary gland cancer	0.00388	0.00916	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—MAP2K2—salivary gland cancer	0.00385	0.00909	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAP2K2—salivary gland cancer	0.00384	0.00907	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—MAP2K2—salivary gland cancer	0.00378	0.00893	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—MAP2K2—salivary gland cancer	0.00377	0.0089	CbGpPWpGaD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—CREBBP—salivary gland cancer	0.00373	0.00881	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—MAP2K2—salivary gland cancer	0.00364	0.00859	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—MAP2K2—salivary gland cancer	0.00363	0.00857	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—FGFR4—salivary gland cancer	0.0036	0.00849	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—MAP2K2—salivary gland cancer	0.00358	0.00845	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—CREBBP—salivary gland cancer	0.00353	0.00833	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—MAP2K2—salivary gland cancer	0.00343	0.0081	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—MAP2K2—salivary gland cancer	0.00327	0.00771	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CREBBP—salivary gland cancer	0.0032	0.00755	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—MAP2K2—salivary gland cancer	0.00309	0.00729	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—MAP2K2—salivary gland cancer	0.00307	0.00725	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CREBBP—salivary gland cancer	0.00302	0.00714	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00298	0.00704	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—MAP2K2—salivary gland cancer	0.00291	0.00686	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—TP53—salivary gland cancer	0.00281	0.00663	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.00274	0.00646	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.00259	0.00611	CbGpPWpGaD
Olopatadine—HRH1—lymph node—salivary gland cancer	0.00256	0.00444	CbGeAlD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—EP300—salivary gland cancer	0.00254	0.006	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00244	0.00575	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—EP300—salivary gland cancer	0.0024	0.00567	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—salivary gland cancer	0.00218	0.00514	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—DTX4—salivary gland cancer	0.00214	0.00505	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—salivary gland cancer	0.00206	0.00486	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—DTX4—salivary gland cancer	0.00202	0.00478	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CYLD—salivary gland cancer	0.00194	0.00457	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PRKDC—salivary gland cancer	0.00186	0.00438	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CYLD—salivary gland cancer	0.00183	0.00432	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—FGF16—salivary gland cancer	0.00177	0.00418	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PRKDC—salivary gland cancer	0.00176	0.00414	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—FGF16—salivary gland cancer	0.00167	0.00395	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00166	0.00392	CbGpPWpGaD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00147	0.00348	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—FGFR4—salivary gland cancer	0.00131	0.00309	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—PTEN—salivary gland cancer	0.00129	0.00305	CbGpPWpGaD
Olopatadine—S100A12—Immune System—DTX4—salivary gland cancer	0.00125	0.00294	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—FGFR4—salivary gland cancer	0.00124	0.00292	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00123	0.00291	CbGpPWpGaD
Olopatadine—S100B—Immune System—DTX4—salivary gland cancer	0.00118	0.00278	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CYLD—salivary gland cancer	0.00113	0.00266	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—WNT5B—salivary gland cancer	0.00111	0.00262	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—FOXO3—salivary gland cancer	0.00109	0.00256	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PRKDC—salivary gland cancer	0.00108	0.00255	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL17RD—salivary gland cancer	0.00107	0.00253	CbGpPWpGaD
Olopatadine—S100B—Immune System—CYLD—salivary gland cancer	0.00107	0.00252	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00106	0.00249	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FGF16—salivary gland cancer	0.00103	0.00243	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—FOXO3—salivary gland cancer	0.00103	0.00242	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRKDC—salivary gland cancer	0.00102	0.00241	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NUP62—salivary gland cancer	0.000989	0.00233	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAML3—salivary gland cancer	0.000979	0.00231	CbGpPWpGaD
Olopatadine—S100B—Immune System—FGF16—salivary gland cancer	0.000975	0.0023	CbGpPWpGaD
Olopatadine—S100B—Immune System—NUP62—salivary gland cancer	0.000935	0.00221	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000912	0.00215	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAP2K2—salivary gland cancer	0.000886	0.00209	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MC3R—salivary gland cancer	0.000872	0.00206	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—HRAS—salivary gland cancer	0.000844	0.00199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00084	0.00198	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAP2K2—salivary gland cancer	0.000838	0.00198	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—MC3R—salivary gland cancer	0.000804	0.0019	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—EP300—salivary gland cancer	0.000788	0.00186	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DTX4—salivary gland cancer	0.000762	0.0018	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FGFR4—salivary gland cancer	0.000762	0.0018	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FBXW7—salivary gland cancer	0.00075	0.00177	CbGpPWpGaD
Olopatadine—S100B—Immune System—FGFR4—salivary gland cancer	0.00072	0.0017	CbGpPWpGaD
Olopatadine—S100B—Immune System—FBXW7—salivary gland cancer	0.000709	0.00167	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CREBBP—salivary gland cancer	0.000658	0.00155	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FOXO3—salivary gland cancer	0.000632	0.00149	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGF16—salivary gland cancer	0.000631	0.00149	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CREBBP—salivary gland cancer	0.000623	0.00147	CbGpPWpGaD
Olopatadine—S100B—Immune System—FOXO3—salivary gland cancer	0.000598	0.00141	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—PIK3CA—salivary gland cancer	0.000583	0.00138	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAML2—salivary gland cancer	0.000548	0.00129	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAP2K2—salivary gland cancer	0.000516	0.00122	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.000516	0.00122	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAP2K2—salivary gland cancer	0.000488	0.00115	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PTEN—salivary gland cancer	0.00047	0.00111	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAG1—salivary gland cancer	0.000468	0.0011	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGFR4—salivary gland cancer	0.000466	0.0011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000464	0.00109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FBXW7—salivary gland cancer	0.000458	0.00108	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—MC3R—salivary gland cancer	0.000454	0.00107	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EP300—salivary gland cancer	0.000448	0.00106	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PTEN—salivary gland cancer	0.000445	0.00105	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EP300—salivary gland cancer	0.000424	0.001	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MC3R—salivary gland cancer	0.000412	0.000973	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FOXO3—salivary gland cancer	0.000387	0.000912	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CREBBP—salivary gland cancer	0.000384	0.000905	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—salivary gland cancer	0.000381	0.000898	CbGpPWpGaD
Olopatadine—S100B—Immune System—CREBBP—salivary gland cancer	0.000363	0.000856	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—salivary gland cancer	0.00036	0.00085	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—salivary gland cancer	0.000332	0.000783	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000316	0.000745	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—salivary gland cancer	0.000314	0.00074	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—WNT5B—salivary gland cancer	0.000309	0.00073	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HRAS—salivary gland cancer	0.000307	0.000724	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL17RD—salivary gland cancer	0.000299	0.000705	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HRAS—salivary gland cancer	0.00029	0.000685	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTEN—salivary gland cancer	0.000274	0.000646	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAML3—salivary gland cancer	0.000273	0.000645	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EP300—salivary gland cancer	0.000261	0.000616	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTEN—salivary gland cancer	0.000259	0.000611	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000259	0.00061	CbGpPWpGaD
Olopatadine—S100B—Immune System—EP300—salivary gland cancer	0.000247	0.000583	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MC3R—salivary gland cancer	0.000244	0.000575	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000235	0.000553	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CREBBP—salivary gland cancer	0.000234	0.000553	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.000216	0.000509	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DTX4—salivary gland cancer	0.000213	0.000503	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—salivary gland cancer	0.000193	0.000456	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000193	0.000455	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000183	0.000432	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—salivary gland cancer	0.000183	0.000431	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HRAS—salivary gland cancer	0.000179	0.000422	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000179	0.000421	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF16—salivary gland cancer	0.000176	0.000416	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—salivary gland cancer	0.000173	0.000409	CbGpPWpGaD
Olopatadine—S100B—Immune System—HRAS—salivary gland cancer	0.000169	0.000399	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTEN—salivary gland cancer	0.000167	0.000395	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EP300—salivary gland cancer	0.00016	0.000377	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAML2—salivary gland cancer	0.000153	0.000361	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000149	0.000352	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000149	0.000352	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000139	0.000328	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAG1—salivary gland cancer	0.000131	0.000308	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGFR4—salivary gland cancer	0.00013	0.000307	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FBXW7—salivary gland cancer	0.000128	0.000302	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000118	0.000279	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—salivary gland cancer	0.000114	0.00027	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000113	0.000267	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HRAS—salivary gland cancer	0.000109	0.000258	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000109	0.000257	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FOXO3—salivary gland cancer	0.000108	0.000255	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AQP1—salivary gland cancer	9.89e-05	0.000233	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAP2K2—salivary gland cancer	8.81e-05	0.000208	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NUP62—salivary gland cancer	7.84e-05	0.000185	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—VCAN—salivary gland cancer	7.78e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH1—salivary gland cancer	7.22e-05	0.00017	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CREBBP—salivary gland cancer	6.55e-05	0.000155	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.15e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—salivary gland cancer	5.58e-05	0.000132	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRAS—salivary gland cancer	5.17e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—salivary gland cancer	4.84e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTEN—salivary gland cancer	4.68e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EP300—salivary gland cancer	4.46e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—salivary gland cancer	3.3e-05	7.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—salivary gland cancer	3.19e-05	7.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRAS—salivary gland cancer	3.05e-05	7.2e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.04e-05	7.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.17e-05	5.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EP300—salivary gland cancer	2.07e-05	4.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.53e-05	3.62e-05	CbGpPWpGaD
